DE10199001I2 - Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür - Google Patents

Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür

Info

Publication number
DE10199001I2
DE10199001I2 DE10199001C DE10199001C DE10199001I2 DE 10199001 I2 DE10199001 I2 DE 10199001I2 DE 10199001 C DE10199001 C DE 10199001C DE 10199001 C DE10199001 C DE 10199001C DE 10199001 I2 DE10199001 I2 DE 10199001I2
Authority
DE
Germany
Prior art keywords
menopause
peri
disorders
packaging
post
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE10199001C
Other languages
English (en)
Other versions
DE10199001I1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PREJAY HOLDINGS Ltd
Woco Investments Ltd
Original Assignee
PREJAY HOLDINGS Ltd
Woco Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27060286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10199001(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by PREJAY HOLDINGS Ltd, Woco Investments Ltd filed Critical PREJAY HOLDINGS Ltd
Application granted granted Critical
Publication of DE10199001I1 publication Critical patent/DE10199001I1/de
Publication of DE10199001I2 publication Critical patent/DE10199001I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE10199001C 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür Active DE10199001I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52083483A 1983-08-05 1983-08-05
US06/635,236 US4826831A (en) 1983-08-05 1984-07-27 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Publications (2)

Publication Number Publication Date
DE10199001I1 DE10199001I1 (de) 2002-03-14
DE10199001I2 true DE10199001I2 (de) 2010-07-08

Family

ID=27060286

Family Applications (5)

Application Number Title Priority Date Filing Date
DE10199010C Active DE10199010I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE10075037C Active DE10075037I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE3486442T Expired - Lifetime DE3486442T3 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE10199001C Active DE10199001I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE1997175086 Active DE19775086I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonalen Behandlung von Stoerungen in der Peri-Menopause Menopause und Post-Menopause und Verpackung mit multiplen Praeparaten dafuer

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DE10199010C Active DE10199010I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE10075037C Active DE10075037I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
DE3486442T Expired - Lifetime DE3486442T3 (de) 1983-08-05 1984-08-02 Verfahren zur hormonellen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1997175086 Active DE19775086I2 (de) 1983-08-05 1984-08-02 Verfahren zur hormonalen Behandlung von Stoerungen in der Peri-Menopause Menopause und Post-Menopause und Verpackung mit multiplen Praeparaten dafuer

Country Status (12)

Country Link
US (2) US4826831A (de)
EP (1) EP0136011B2 (de)
AT (1) ATE147987T1 (de)
CA (1) CA1240927A (de)
DE (5) DE10199010I2 (de)
DK (2) DK165390C (de)
IL (1) IL72556A (de)
LU (5) LU90107I2 (de)
MX (1) MX9203720A (de)
NL (5) NL970026I1 (de)
NZ (1) NZ209066A (de)
PH (1) PH24052A (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
EP0300523B1 (de) * 1987-07-06 1991-08-14 Akzo N.V. Pharmazeutische Dosierungseinheit zur Vorbeugung bzw. Behandlung von klimakterischen Beschwerden
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (de) * 1987-12-22 1989-06-28 Akzo N.V. Pharmazeutische Dosierungseinheit zur Behandlung von klimakterischen Beschwerden und Osteoporosis
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
WO1990010462A1 (en) * 1989-03-10 1990-09-20 Endorecherche Inc. Combination therapy for treatment of estrogen sensitive diseases
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US6037339A (en) * 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19510861A1 (de) * 1995-03-16 1996-09-19 Schering Ag Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
EP1098653A2 (de) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Subkutane verabreichung von medroxyprogesteronacetat zur kontrazeption
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
CA2311937A1 (en) * 1998-10-09 2000-04-20 Pharmacia & Upjohn Company Llc Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US20020151530A1 (en) 2000-12-22 2002-10-17 Leonard Thomas W. Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
EA200301022A1 (ru) * 2001-03-16 2004-02-26 Уайт Гормональная заместительная терапия
PL364675A1 (en) * 2001-03-16 2004-12-13 Wyeth Estrogen replacement therapy
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
US20030004145A1 (en) 2001-05-16 2003-01-02 Leonard Thomas W. Treatment of conditions relating to hormone deficiencies by administration of progestins
JP2004521951A (ja) * 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
WO2003018026A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
SI1453521T1 (sl) 2001-12-05 2013-11-29 Teva Women's Health, Inc. Oralni kontraceptiki za preprečevanje nosečnosti in zmanjševanje predmenstrualne simptomatike
WO2003084547A1 (en) * 2002-04-03 2003-10-16 Barr Laboratories, Inc. Step-down estrogen therapy
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
KR20050059092A (ko) * 2002-08-28 2005-06-17 로버트 캐스퍼 에스트로겐 보충 요법
EP1462106A1 (de) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmazeutishe Zusammensetzungen und Kits enthaltend 17-Betaestradiol und Progesteron zur Behandlung von Gynäcologischen Storungen
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (de) * 2003-04-11 2009-03-18 Barr Lab Inc Verfahren zur verabreichung von östrogenen und gestagenen
EP1624848A4 (de) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc Verfahren zur hormonbehandlung mit kontrazeptva-schemata mit verlängertem zyklus
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
AU2004275470B2 (en) * 2003-09-29 2010-12-02 Novo Nordisk Health Care Ag Improved stability of progestogen formulations
DK1670440T3 (da) * 2003-09-29 2014-07-07 Novo Nordisk As HRT formuleringer
AU2005249401A1 (en) * 2004-05-26 2005-12-15 Wyeth Compositions and methods for treatment of premenstrual dysphoric disorder
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026679A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
CA2601773A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US8217024B2 (en) * 2005-12-27 2012-07-10 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral
EP2164498A4 (de) 2007-06-04 2010-09-08 Univ California Schwangerschaftshormonkombination zur behandlung von autoimmunkrankheiten
MX356702B (es) 2010-04-15 2018-06-11 Bayer Ip Gmbh Formas de dosificación sólidas orales con dosis muy bajas para la hrt.
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015168002A1 (en) 2014-04-28 2015-11-05 The Regents Of The University Of California Pharmaceutical packaging for estriol therapy
EP3137087B1 (de) * 2014-04-28 2023-09-06 The Regents of the University of California Östrogenkombination zur behandlung von multipler sklerose
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2016036719A1 (en) 2014-09-02 2016-03-10 The Regents Of The University Of California Estrogen therapy for brain gray matter atrophy and associated disability
ES2957543T3 (es) 2014-09-29 2024-01-22 Univ California Composiciones y métodos para mantener la función cognitiva
EP3277285A4 (de) 2015-03-30 2018-12-19 The Regents of the University of California Verfahren zur überwachung einer estrioltherapie
CA2988498C (en) 2015-06-18 2022-02-08 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
RS62844B1 (sr) 2015-06-18 2022-02-28 Estetra Srl Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
GB1578340A (en) * 1977-11-15 1980-11-05 Normalair Garrett Ltd Mechanical hands eg for diving apparatus
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms

Also Published As

Publication number Publication date
DE10199010I1 (de) 2002-05-08
ATE147987T1 (de) 1997-02-15
NL970026I1 (nl) 1997-10-01
NL300033I1 (nl) 2001-03-01
NZ209066A (en) 1988-01-08
DE3486442D1 (de) 1997-03-06
IL72556A (en) 1989-05-15
NL970037I1 (nl) 1998-02-02
NL970037I2 (nl) 2004-04-01
EP0136011B2 (de) 2004-06-09
LU90696I2 (fr) 2001-02-13
MX9203720A (es) 1992-07-31
LU90697I2 (fr) 2001-02-13
USRE36247E (en) 1999-07-06
NL980038I2 (nl) 2005-06-01
LU91096I2 (fr) 2004-11-30
EP0136011B1 (de) 1997-01-22
DK377084A (da) 1985-02-06
NL980038I1 (nl) 1999-02-01
NL300022I1 (nl) 2001-01-02
EP0136011A3 (de) 1986-07-16
DE19775086I2 (de) 2001-08-23
LU90343I2 (fr) 1999-03-29
CA1240927A (en) 1988-08-23
NL300033I2 (nl) 2004-04-01
DK175317B1 (da) 2004-08-16
EP0136011A2 (de) 1985-04-03
DE10199010I2 (de) 2010-01-28
IL72556A0 (en) 1984-11-30
DK377084D0 (da) 1984-08-03
LU90107I2 (fr) 1997-12-17
DE3486442T3 (de) 2005-05-12
DK165390C (da) 2004-04-26
DE3486442T2 (de) 1997-06-05
DK165390B (da) 1992-11-23
DE10075037I1 (de) 2001-03-01
PH24052A (en) 1990-03-05
DE10199001I1 (de) 2002-03-14
DK200400365A (da) 2004-03-04
DE10075037I2 (de) 2010-01-28
NL300022I2 (nl) 2004-04-01
US4826831A (en) 1989-05-02

Similar Documents

Publication Publication Date Title
ATE147987T1 (de) Verfahren zur hormonalen behandlung von störungen in der peri-menopause, menopause und post- menopause und verpackung mit multiplen präparaten dafür
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
NL7602725A (nl) Werkwijze en inrichting ter verwijdering van stik- stofoxyden.
DE3873836D1 (de) Aluminiumborat-whisker und verfahren zu ihrer herstellung.
JPS51134071A (en) Method to eliminate crystal defects of silicon
DE69330429D1 (de) Verfahren zur behandlung von haarausfall
DE68902668D1 (de) Verfahren zur thermischen behandlung von galliumarsenid-einkristallen.
JPS5259124A (en) Photopolymerizable unsaturated ketones and process for preparation thereof
JPS51122588A (en) Transport device
JPS5244959A (en) Distributing apparatus
JPS51128211A (en) Synthesizer for receiver
JPS5244975A (en) Super heavy article transporting apparatus
JPS51146077A (en) Method of and apparatus for removing matter attached to beltconveyor
JPS51125945A (en) Treating method of sludge
JPS521807A (en) Noise reducing apparatus of railway vehicle
AT343559B (de) Verfahren zur behandlung von abwasser, insbesondere von abwasser, welches vom wirbelschicht-cracken stickstoffhaltiger kohlenwasserstoffole stammt
JPS526655A (en) Method for killing insects in garbage vessel
JPS51113245A (en) Method for manufacturing internal box of refrigieter
DE68918928D1 (de) Verfahren und Gerät zur Herstellung von kreuzgelegten Vliesstoffen.